• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PACS Group Inc. filed SEC Form 8-K: Other Events

    9/10/25 9:00:10 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    pacs-20250909
    false000200118400020011842025-09-092025-09-09

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): September 9, 2025
    PACS GROUP, INC.
    (Exact name of registrant as specified in its charter)
    Delaware001-4201192-3144268
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification Number)
    262 N. University Ave.
    Farmington, Utah 84025
    (Address of principal executive offices, including Zip Code)
    Registrant’s telephone number, including area code: (801) 447-9829
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange
    on which registered
    Common Stock, $0.001 par value per sharePACSThe New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 8.01 Other Events.
    Update on NYSE Listing
    PACS Group, Inc. (the “Company”) is announcing that on September 9, 2025, the New York Stock Exchange (“NYSE”) Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to reassessment on an ongoing basis, to regain compliance with Section 802.01E of the NYSE’s Listed Company Manual, Annual and Quarterly Report Timely Filing Criteria.
    The Company previously announced that it was unable to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (collectively, the “Delinquent Filings”), respectively, due to an ongoing independent investigation by the Company’s independent Audit Committee. In addition, the Company previously announced that (i) its condensed combined/consolidated financial statements as of March 31, 2024, and for the three months then ended, included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 13, 2024 (as amended on May 21, 2024) and (ii) its condensed combined/consolidated financial statements as of June 30, 2024, and for the three and six months then ended, included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 12, 2024 (collectively, the “Prior Financial Statements”) should no longer be relied upon.
    The Company is working diligently to restate the Prior Financial Statements and file the Delinquent Filings and intends to regain compliance with Section 802.01E of the NYSE’s Listed Company Manual as soon as feasible and within the granted additional period. The NYSE informed the Company that the NYSE will monitor the Company and its progress towards filing the Delinquent Filings.
    Cautionary Statement Regarding Forward-Looking Statements
    This Current Report on Form 8-K contains “forward-looking statements.” These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “outlook,” “forecast,” “target,” “trend,” “plan,” “goal,” or other words of comparable meaning or future-tense or conditional verbs such as “may,” “will,” “should,” “would,” or “could.” Statements concerning the Company’s future are forward-looking statements, and are based on management’s current expectations, assumptions and beliefs about the Company’s business, financial performance, operating results, the industry in which the Company operates and possible future events. These statements include, but are not limited to, statements regarding the Company’s expectations regarding the timing of the restatement and its ability to file the Delinquent Filings. Forward-looking statements convey the Company’s expectations, intentions, or forecasts about future events, circumstances, results, or aspirations. Forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions, which may change over time and many of which are beyond the Company’s control, and that could cause the Company’s actual results to materially and adversely differ from those expressed in any forward-looking statement, including the outcome of any ongoing government or internal investigations, risks associated with litigation, and the other risks described in the Company’s Quarterly Report on Form 10-Q for the three months ended June 30, 2024 and other filings with the Securities and Exchange Commission. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such date.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    PACS GROUP, INC.
    Date: September 10, 2025
    By:
    /s/ Jason Murray
    Jason Murray
    Chief Executive Officer

    Get the next $PACS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2025$44.00Overweight
    Analyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 3,348 shares, decreasing direct ownership by 0.89% to 374,870 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:59:36 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Legal Officer & Sec. Mitchell John Todd covered exercise/tax liability with 9,541 shares, decreasing direct ownership by 1% to 868,150 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:58:47 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    President & COO Jergensen Joshua covered exercise/tax liability with 21,998 shares, decreasing direct ownership by 0.81% to 2,703,682 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:57:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    PACS Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/23/25 4:02:39 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/1/25 4:02:18 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form DEF 14A filed by PACS Group Inc.

    DEF 14A - PACS Group, Inc. (0002001184) (Filer)

    11/25/25 4:03:34 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time

    PACS Group, Inc. (NYSE:PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Financial Officer, will present at the annual J.P. Morgan Healthcare Conference in San Francisco. The presentation audio will be webcast live on Tuesday, January 13, 2026, at 5:15 pm Pacific Time. To access the live webcast, please visit the Investor Relations section of PACS's website at https://ir.pacs.com or at https://ir.pacs.com/news-events/ir-calendar. An archived version of the webcast will be available for at least 30 days following the presentation. About PACS™ PACS Group, Inc. is a holding company investing in post-a

    1/12/26 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Expands Management Team, Adding New Chief Compliance Officer and Chief Human Resource Officer to Executive Leadership Team

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announces the appointments of Kelly Priegnitz as Chief Compliance Officer and Trent Bingham as Chief Human Resources Officer. Mr. Bingham joined PACS on Nov. 10, while Ms. Priegnitz began her role on Dec. 1. Ms. Priegnitz joins PACS after serving as Executive Vice President and Chief Legal and Compliance Officer of Pinnacle Treatment Centers since 2020. Prior to her service at Pinnacle Treatment Centers, Ms. Priegnitz held a variety of senior healthcare compliance leadership roles throughout her career, including Senior Vic

    12/8/25 4:12:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on PACS Group with a new price target

    Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00

    12/17/25 9:24:40 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces Business Updates

    Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

    12/1/25 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care